Price$3.36-0.12 (-3.31%)
01:30 PM07:45 PM
News · 26 weeks46-40%
2026-04-192026-10-11
Mix1890d
- Insider11(61%)
- SEC Filings4(22%)
- Other2(11%)
- Earnings1(6%)
Latest news
25 items- INSIDERSEC Form 4 filed by GoodRx Holdings Inc.4 - GoodRx Holdings, Inc. (0001809519) (Issuer)
- INSIDERSEC Form 4 filed by GoodRx Holdings Inc.4 - GoodRx Holdings, Inc. (0001809519) (Issuer)
- INSIDERSEC Form 4 filed by GoodRx Holdings Inc.4 - GoodRx Holdings, Inc. (0001809519) (Issuer)
- INSIDERChief Accounting Officer Chan Thomas (Tc) converted options into 2,101 shares and covered exercise/tax liability with 1,069 shares, increasing direct ownership by 8% to 14,578 units (SEC Form 4)4 - GoodRx Holdings, Inc. (0001809519) (Issuer)
- INSIDEROfficer Fengler Justin converted options into 3,087 shares and covered exercise/tax liability with 1,354 shares, increasing direct ownership by 3% to 52,509 units (SEC Form 4)4 - GoodRx Holdings, Inc. (0001809519) (Issuer)
- PRFrom Kids to Canines: GoodRx Launches Companion Family Plan to Bring Healthcare Savings to the Whole HouseholdNew $24.99 monthly plan includes a primary member and up to four dependents, including children, adults, and pets, with more than 250 generic medications available for free and savings on dental, vision, lab and imaging services Brief Summary: GoodRx launched the Companion Family Plan for $24.99 per month or $16.99 per month when paying annually The plan covers a primary member and up to four dependents, including children, adult family members, and pets, with no age restrictions Members can access more than 250 eligible medications for free and hundreds more for under $10 at nearly every pharmacy nationwide, along with savings on dental, vision, lab, and imaging services The
- SECAmendment: SEC Form SCHEDULE 13D/A filed by GoodRx Holdings Inc.SCHEDULE 13D/A - GoodRx Holdings, Inc. (0001809519) (Subject)
- INSIDERLarge owner Francisco Partners Iv, L.P. sold $5,477,482 worth of shares (1,567,044 units at $3.50) (SEC Form 4)4 - GoodRx Holdings, Inc. (0001809519) (Issuer)
- INSIDERLarge owner Francisco Partners Iv, L.P. converted options into 7,500,000 shares, disposed of 4,739,005 shares and sold $4,201,230 worth of shares (1,193,951 units at $3.52) (SEC Form 4)4 - GoodRx Holdings, Inc. (0001809519) (Issuer)
- SECSEC Form 144 filed by GoodRx Holdings Inc.144 - GoodRx Holdings, Inc. (0001809519) (Subject)
- INSIDERChief Accounting Officer Chan Thomas (Tc) converted options into 10,115 shares and covered exercise/tax liability with 5,149 shares, increasing direct ownership by 58% to 13,546 units (SEC Form 4)4 - GoodRx Holdings, Inc. (0001809519) (Issuer)
- INSIDEROfficer Fengler Justin converted options into 48,532 shares and covered exercise/tax liability with 21,407 shares, increasing direct ownership by 115% to 50,776 units (SEC Form 4)4 - GoodRx Holdings, Inc. (0001809519) (Issuer)
- INSIDERSEC Form 4 filed by Officer Fengler Justin4 - GoodRx Holdings, Inc. (0001809519) (Issuer)
- INSIDERNew insider Fengler Justin claimed ownership of 23,651 shares (SEC Form 3)3 - GoodRx Holdings, Inc. (0001809519) (Issuer)
- SECGoodRx Holdings Inc. filed SEC Form 8-K: Leadership Update8-K - GoodRx Holdings, Inc. (0001809519) (Filer)
- SECSEC Form 10-Q filed by GoodRx Holdings Inc.10-Q - GoodRx Holdings, Inc. (0001809519) (Filer)
- SECGoodRx Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - GoodRx Holdings, Inc. (0001809519) (Filer)
- PRGoodRx Reports Second Quarter 2026 ResultsPharma Direct and Subscription Revenue Increased 76% and 39%, Respectively, Year-Over-Year Company Raises Full-Year 2026 Revenue and Adjusted EBITDA Expectations GoodRx Holdings, Inc. (NASDAQ:GDRX) ("we," "us," "our," "GoodRx," or the "Company"), the leading platform for medication savings in the U.S., has released its financial results for the second quarter of 2026. Second Quarter 2026 Highlights Revenue of $200.4 million Net income of $8.5 million; Net income margin of 4.3% Adjusted Net Income1 of $26.8 million; Adjusted Net Income Margin1 of 13.4% Adjusted EBITDA1 of $63.7 million; Adjusted EBITDA Margin1 of 31.8% Net cash provided by operating activities of $80.8 m
- INSIDEROfficer Mcginnis Christopher A converted options into 36,988 shares and covered exercise/tax liability with 16,294 shares, increasing direct ownership by 12% to 198,310 units (SEC Form 4)4 - GoodRx Holdings, Inc. (0001809519) (Issuer)
- INSIDEROfficer Barnes Wendy Lynn covered exercise/tax liability with 120,456 shares and converted options into 277,288 shares, increasing direct ownership by 27% to 741,657 units (SEC Form 4)4 - GoodRx Holdings, Inc. (0001809519) (Issuer)
- INSIDERChief Accounting Officer Chan Thomas (Tc) converted options into 5,792 shares and covered exercise/tax liability with 2,947 shares, increasing direct ownership by 50% to 8,580 units (SEC Form 4)4 - GoodRx Holdings, Inc. (0001809519) (Issuer)
- PRGoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference CallGoodRx Holdings, Inc. (NASDAQ:GDRX) ("GoodRx" or the "Company"), the leading platform for prescription savings in the U.S., today announced it will release its second quarter 2026 financial results after U.S. markets close on Wednesday, August 5, 2026. GoodRx management will also hold a conference call and webcast the following morning, Thursday, August 6, 2026 at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company’s business outlook. To access the conference call, please pre-register using this link. Registrants will receive a confirmation with dial-in details and a unique passcode required to join. The call will also be webcast live on the Company’s in
- SECGoodRx Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - GoodRx Holdings, Inc. (0001809519) (Filer)
- INSIDERDirector Rey-Giraud Agnes was granted 73,434 shares, increasing direct ownership by 21% to 426,286 units (SEC Form 4)4 - GoodRx Holdings, Inc. (0001809519) (Issuer)
- INSIDERDirector Kennedy Kelly J. was granted 73,434 shares, increasing direct ownership by 55% to 207,645 units (SEC Form 4)4 - GoodRx Holdings, Inc. (0001809519) (Issuer)
GDRX FAQ
7 questionsWhat does GoodRx Holdings Inc. do?
GoodRx Holdings, Inc., through its subsidiaries, provides information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including telehealth services. The company serves pharmacy benefit managers that manage formularies...Where does GDRX stock trade?
GoodRx Holdings Inc. (GDRX) is listed on NASDAQ.What sector and industry is GDRX in?
GoodRx Holdings Inc. operates in the Technology sector, EDP Services industry.When did GoodRx Holdings Inc. go public?
GoodRx Holdings Inc. (GDRX) completed its IPO in 2020.What are analysts saying about GDRX?
GoodRx Holdings Inc. has had 8 recent analyst actions on file. The most recent action was from Analyst: Neutral on 2026-02-27. Recent price targets range from $275.00 to $1000.00.What companies are similar to GDRX?
Notable peers in the same industry include NEE (NextEra Energy Inc.), PDD (PDD Holdings Inc.), INFY (Infosys Limited), WDAY (Workday Inc.), ZS (Zscaler Inc.). Compare GDRX side-by-side with any of them on Quantisnow.How can I track GDRX on Quantisnow?
Quantisnow aggregates GoodRx Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow GDRX to receive live email and push alerts on every new disclosure.